logo
Plus   Neg
Share
Email

PTC Therapeutics Announces Biologics Facility In New Jersey - Quick Facts

PTC Therapeutics, Inc. (PTCT) said, under a long-term lease agreement with Bristol-Myers Squibb Company (BMY), PTC will gain access to Hopewell facility on the BMS Hopewell, N.J. campus. PTC plans to relocate its global discovery and research operations to the site in 2020.

Stuart Peltz, CEO, PTC Therapeutics, said: "Obtaining this facility allows PTC to execute on our plans of rapidly advancing our gene therapy pipeline. Access to best-in-class technology and highly qualified biologics operation specialists is key for PTC to meet our goal of becoming a leader in gene therapy."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
Follow RTT